3 models fit Transcontinental Realty Investors Inc. Common Stock and they partly agree: 2 of 3 land within 15% of the average.
Two or more of our models back this value.
Near fair value(i)Bronze58
Valued as a mature, profitable company: P/E comparison, EV/EBITDA comparison, and Graham number.
ACCE opinionTranscontinental Realty Investors Inc. Common Stock (TCI)
Fair value (3 models)
$46.52
ACCE price target
$42.00
Rating
Fairly valued
Horizon
12 months
Fair value published on 20 Oct 2026, 14:06 CEST; previously $47.39 since 15 Oct 2026, 00:00 CEST.
ACCE price target published on 15 Oct 2026, 00:00 CEST.
Rating published on 20 Oct 2026, 14:06 CEST.
Price used: $48.45 at the close on 23 Oct 2026, 22:00 CEST.
Models: P/E comparison, EV/EBITDA comparison, and Graham number.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
4.2% above
-4.0% to fair value
ACCE score
50
out of 100
P/E
52.1x
1-year return
+7.7%
Dividend yield
0.00%
Transcontinental Realty Investors Inc. Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Transcontinental Realty Investors owns and operates income-producing commercial and multifamily real estate, with its value tied to the rent rolls and occupancy of its property portfolio rather than to a branded product line. Its edge is the asset base itself, held in a concentrated Texas and Southwest footprint, which gives it operating leverage when local rents rise. Revenue growth of 5.8% is respectable, but the business is not yet converting it into profit: operating margin sits at -18.2% against a 38.4% gross margin, and ROE of 1.0% says little is coming back to shareholders. The forward P/E of 19.7 against a trailing 53.0 suggests the market expects earnings to recover, which is the main thing to test in the filings before any further work. The score of 50/100 and absence from major indices point to a thinly followed name where that recovery case has to be built from the company's own disclosures.
⚠ Investor warnings · 4 flagsAI-assisted·How I use AI
high
Free cash flow deeply negative
Free cash flow is $-82,378,000 against a $423M market cap, and operating margin is -18.2%. Net margin of +16.1% does not show up as cash, so the reported profit quality is questionable.
high
Earnings collapsed year on year
Earnings are down 96.4% YoY while revenue grew 5.8%, and the 5-year revenue CAGR is -1.1%. Top-line growth is not translating into profit.
moderate
Thin return on equity
ROE is +1.0% and the P/E is 51.8, so the stock is priced for earnings the business is not currently generating.
moderate
Price well above ACCE target
The price of $48.45 sits 15.4% above the ACCE price target of $42.00, and 4.2% above the model fair value of $46.52.
AI research notes
AI-assisted·How I use AIWritten Oct 21, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
Revenue grew 5.8% year over year in the latest 10-Q, a sharper rebound than its five-year trend.
Net margin of 16.1% shows the company keeps a healthy share of each dollar of revenue as profit.
Debt to equity of 0.25 means the balance sheet carries modest borrowing relative to its equity base.
Why it could disappoint
Free cash flow over the last twelve months was negative $82M, so the business is consuming cash rather than generating it.
Return on equity of 1.0% and return on invested capital of 1.1% show very little return on the capital shareholders have put in.
The stock trades at a trailing P/E of 51.8x, far above the sector median forward P/E of 17.2x, and 15.4% above the $42.00 ACCE price target.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.
Next results
Nov 5, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
PRO
Ask ACCE
Valuation
INVESTOR
Where TCI's valuation models land
Price
$48.45
Model fair value
$46.52
Model range
$40.73 to $58.76
Fair value $46.52
Price $48.45
The price sits inside the model range.
Model
Fair value
Upside
EV/EBITDA comparison
Graham number
P/E comparison
Create a free account: 5 full stock pages a month, no card.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
Quality
INVESTOR
Quality and conviction INVESTOR FEATURE
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
+A plain reason under every score
+Conviction breakdown and growth / value / quality / momentum scores
+Score history: how each score moved over time
Analysts
Wall Street consensus
No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
+Price-target low / average / high vs the current price, with implied upside
+Forward revenue and EPS consensus by fiscal year
+ACCE fair-value models lined up against the Street
Smart Money
PRO
In one line
Trades are only made public after a delay. We show the delay so you know how old the news is.